当前位置: 首页 > 详情页

Body mass index and all-cause mortality in patients with atrial fibrillation: insights from the China atrial fibrillation registry study

文献详情

资源类型:
机构: [1]Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, No. 2 Beijing Anzhen Road, Chaoyang District, Beijing 100029, China [2]Heart Health Research Center, Beijing, China [3]University of New South Wales, Sydney, Australia [4]Cardiovascular Hospital, First Affiliated Hospital of Zhengzhou University, No. 2 Building East Road, Zhengzhou 450052, Henan, China [5]School of Statistics, Faculty of Economics and Management, East China Normal University, Shanghai, China [6]Montreal Heart Institute, Université de Montréal, Montreal, QC, Canada
出处:
ISSN:

关键词: All-cause mortality Arial fibrillation Body mass index

摘要:
Background: Impact of body mass index (BMI) on all-cause mortality in atrial fibrillation (AF) patients remains controversial. Methods: A total of 10,942 AF patients were prospectively enrolled and categorized into four BMI groups: underweight (BMI < 18.5 kg/m 2 ), normal weight (BMI 18.5–24 kg/m 2 ), overweight (BMI 24–28 kg/m 2 ) and obesity (BMI ≥ 28 kg/m 2 ). The primary outcome was all-cause mortality. Different Cox proportional hazards models were performed to evaluate the association between BMI and all-cause mortality. Results: During a median follow-up of 30 months (IQR 18–48 months), 862 deaths events occurred. Compared to normal BMI, higher BMI was associated with a lower mortality risk (overweight: HR 0.70; 95% CI 0.61–0.81, P < 0.0001 and obesity: HR 0.54; 95% CI 0.44–0.67, P < 0.0001) and lower BMI was associated with a higher mortality risk (HR 2.23, 95% CI 1.67–2.97, P < 0.0001). Conclusion: A reversed relationship between BMI and all-cause mortality in AF patients was found. Higher risk of mortality was observed in underweight patients compared to patients with a normal BMI, while overweight and obese patients had a lower risk of all-cause mortality. Clinical trial registration: URL: http://www.chictr.org.cn/showproj.aspx?proj=5831. Unique identifier: ChiCTR-OCH-13003729. © 2019, Springer-Verlag GmbH Germany, part of Springer Nature.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 2 区 医学
小类 | 3 区 心脏和心血管系统
最新[2023]版:
大类 | 2 区 医学
小类 | 3 区 心脏和心血管系统
第一作者:
第一作者机构: [1]Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, No. 2 Beijing Anzhen Road, Chaoyang District, Beijing 100029, China
通讯作者:
通讯机构: [1]Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, No. 2 Beijing Anzhen Road, Chaoyang District, Beijing 100029, China [4]Cardiovascular Hospital, First Affiliated Hospital of Zhengzhou University, No. 2 Building East Road, Zhengzhou 450052, Henan, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16399 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院